Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05589155
Other study ID # HS-2022-0156
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date July 1, 2023

Study information

Verified date October 2022
Source San Diego State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 1, 2023
Est. primary completion date July 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Diagnosed with type II diabetes for at least 3 months - Between the age of 18-64 - BMI = 25 - Monitors blood glucose regularly (at least once per day) - Owns or has access to a bathroom weight scale - Owns a smartphone and willing to download mobile app Exclusion Criteria: - Does not check blood glucose at least once per day - On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications. Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are oka

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mobile health application
Intervention will be with mobile health application

Locations

Country Name City State
United States San Diego State University San Diego California

Sponsors (1)

Lead Sponsor Collaborator
San Diego State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of mHealth apps at changing bodyweight assessed by bodyweight measurements over 6 months Determine if mhealth app is an effective weight loss modality compared to standard weight loss program (control)
Outcome measure will be body weight in kg
6 months
Primary Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire Compare and determine which intervention promotes self-efficacy in weight management.
Reporting will be on a scale of 0-100, with higher scores indicating higher self-efficacy
6 months
Primary Long term change in diabetes via A1c Compare and determine which intervention elicits the most change towards diabetes via HbA1c
Outcome measure will be HbA1c
6 months
Primary Long term change in diabetes via fasting blood glucose Compare and determine which intervention elicits the most change towards diabetes via fasting blood glucose
Outcome measure will be fasting blood glucose
6 months
Secondary Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire Comparing the two arms to determine which leads to greater quality of life (QOL)
Measures will be reported on a scale of 1-5 across four domains. Scores will be converted to a scale of 0-100
6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2